97743-99-2 Usage
Uses
Used in Pharmaceutical Industry:
1-(3-MethylaMinopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile is used as an antidepressant for the treatment of depression and related disorders. It functions as an inhibitor of serotonin (5-HT) uptake, which helps to increase the levels of serotonin in the brain, leading to improved mood and reduced symptoms of depression.
Used in Chemical Research:
1-(3-MethylaMinopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile can be used as a research compound in the field of chemistry, particularly for studying the structure-activity relationships of isobenzofuran derivatives and their potential applications in various industries.
Used in Drug Development:
As a derivative of isobenzofuran, 1-(3-MethylaMinopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile may have potential as a lead compound in drug development for the treatment of various diseases and conditions. Further research and development are required to explore its therapeutic potential and optimize its properties for specific applications.
Check Digit Verification of cas no
The CAS Registry Mumber 97743-99-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,7,4 and 3 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 97743-99:
(7*9)+(6*7)+(5*7)+(4*4)+(3*3)+(2*9)+(1*9)=192
192 % 10 = 2
So 97743-99-2 is a valid CAS Registry Number.
97743-99-2Relevant academic research and scientific papers
Process for the preparation of escitalopram
-
Page/Page column 9, (2009/02/10)
The present invention relates to a novel process for the preparation of Escitalopram, which comprises: (ii) de-methylating (±)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile (Formula II) (Citalopram) to produce (±)-1-[3-(methylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile (desmethyl Citalopram) (XII), (iii) isolating the pure desmethyl Citalopram (XII), (iv) separating the enantiomers from the pure desmethyl Citalopram (XII) with an optically active acid to obtain (S)-(+)-1-[3-(methylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile ((S)-(+)-desmethyl Citalopram) (XIII), (v) methylating an enantiomerically pure compound (XIII) using suitable methylating agent to produce Escitalopram (I).
